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The eight RNA genome segments of influenza A viruses have been shown to encode 
at  least  10  polypeptides(1-6).  Previous  immunologic studies  on  these  polypeptides 
have been limited primarily to the major virion structural  proteins, hemagglutinin, 
nucleocapsid protein (NP), 1 neuraminidase, and the membrane protein. Such studies 
have  included  analyses  of  antigenic  cross-reactivities  (7-10)  and  localization  of 
antigens within and on the surfaces of virus-infected cells (11-17). These studies have 
shown that in addition to the major glycoprotein antigenic shifts that are thought to 
result  from  molecular  reassortment  of the  viral  genome  segments  during  double 
infection, influenza viruses undergo a gradual antigenic drift due to mutations in the 
RNA coding for the viral proteins  (8).  Such antigenic drift has been detected in the 
hemagglutinin and neuraminidase glycoproteins (7,  10) and, to a lesser extent, in the 
NP polypeptide (9). 
The  smallest  influenza  viral  genome  segment  (segment  8)  contains  overlapping 
genes  (18)  coding for two nonstructural  proteins  designated  NS1  (~23,000  mol wt) 
and NS2 (~14,000  mol wt). The antigenic properties of these nonstructural  proteins 
have not been investigated previously. Further, there is little information available on 
the function  of these polypeptides, although the largest nonstructural  protein  (NSa) 
is often the most abundant viral polypeptide in influenza A virus-infected cells (I-3). 
Cell fractionation experiments have shown that NS1 is associated with cell fractions 
containing polysomes (19,  20)  and with nucleoplasm and nucleolar fractions (1,  21- 
23).  NS1  has  also  been  shown  to  form  electron-dense  cytoplasmic  inclusions  in 
association  with  RNA  (21,  24).  We  have  previously  shown  (20)  that  milligram 
quantities  of purified influenza A  virus NS1 protein can be obtained in the form of 
paracrystalline inclusions isolated from the cytoplasm of infected cells. This has made 
it feasible to produce antiserum specific for this polypeptide. This report describes the 
first immunologic characterization of purified NS1 protein, including the demonstra- 
tion of antigenic  cross-reactivity between  the NS1  proteins  from different  influenza 
virus strains by immunoprecipitation and competition radioimmunoassay. 
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Materials and Methods 
Virus and Cells.  Stock A/WSN/33  (HaNa) virus was  grown  in MDBK cells  (25). Stock 
A/PR/8/34  (H1N1), A/FW/1/50  (H1N1), A/USSR/90/77  (HIN1),  A/RI/5+/57  (HzN2), 
A/Jap/305/57  (H2Nz), A/Victoria/3/75 (HaN2), A/Swine/1976/31  (H~wN1), and B/Lee/40 
viruses were grown in the allantoic cavity of embryonated hens' eggs. Seed virus diluted into 
Eagle's minimal essential medium (MEM) with 1% bovine serum albumin (BSA) was injected 
into the allantoie cavity of 10-11-d-old embryonated eggs using a  volume of 0.2 ml per egg. 
After a  2-d  incubation at  37°C,  the  infected eggs  were  transferred to  4°C  overnight. The 
allantoic fluid was then harvested, and cells and cell debris were removed by pelleting for 20 
min at  1,000 g. The supernatant was frozen in aliquots and stored at -80°C. MDBK (bovine 
kidney), MDCK  (canine kidney), and BHK21-F  (baby hamster  kidney) cells  were  grown 
according to previously described procedures (25-27). 
Isolation of Cytoplasmic Inclusions.  Monolayer cultures of BHK21-F cells grown in  100-ram 
plastic petri dishes were  harvested by scraping at  20-24 h  after infection with A/WSN/33 
(WSN') virus, as described previously (20). The ceils were pelleted and resuspended in RSB 
(0.01 M  NaCI, 0.005  M  MgCI2, 0.01 M Tris HC1, pH 7.4) and kept on ice for 20 min before 
homogenizing for 40 strokes  with a Dounce homogenizer. The extract was centrifuged at 800 
g for 10 min, and the pellet was resuspended to 10 ml in Tris-EDTA (0.01 M Tris-HC1, 0.02 M 
EDTA) and 1% Triton XI00 and homogenized for an additional 20 strokes.  The nuclei were 
pelleted at 800 g for 10 min, and the supernatant fractions from the two homogenizations  were 
pooled and extracted with trichlorotrifluoroethane (28), first with twice the sample volume of 
fluorocarbon and then three times with equal volumes of sample and fluorocarbon. 
The aqueous extract was pelleted at 20,000 rpm for 30 min in an SW27 rotor and resuspended 
in 2.5 ml of Tris-EDTA and 1% Triton X100. After an 18-h incubation at 4°C, the sample was 
layered onto discontinuous  sucrose gradients prepared as follows (wt/wt) in Tris-EDTA (top to 
bottom: 2.5-ml sample; 2.5 ml each of 45%, 50%, 55%, and 60% sucrose)  and centrifuged at 
35,000 rpm for 90 min in an SW41 rotor. The band of inclusions forming at the 55/60% sucrose 
interface was collected, diluted in Tris-EDTA, and washed by pelleting (three times for 15 rain 
at 25,000 rpm in an SW41  rotor) in Tris-EDTA before resuspension in that buffer. 
Immune Sera.  The purity of NS1 from batches of inclusions was ascertained by polyacryl- 
amide gel  etectrophoresis  (PAGE)  (see below).  For immunization, purified inclusions were 
solubilized by addition of urea to 6 M  and KCI to 1 M  and incubating at 60°C for 24 h. An 
aliquot of 500/~g of protein in 6 M  urea was emulsified in Freund's complete adjuvant and 
injected subcutaneously into adult rabbits. At 2-wk intervals, second and third injections  of 250 
/~g each in Freund's incomplete adjuvant were given subcutaneously. After another 2 wk, 250 
#g of protein from inclusions solubilized as above and readjusted to physiologic conditions by 
dialysis against phosphate-buffered saline (PBS) was injected intravenously into the marginal 
ear vein. Bleeding was done 1 wk after the final injection. 
Antiserum to the structural proteins of WSN virus was obtained by immunization  of rabbits 
with ether-disrupted purified virions. The first  intravenous injection consisted of 200/~g of 
protein. After 2 wk, three intraperitoneal injections of 500 btg each were given at 2-mo intervals. 
Serum was collected 2 wk after the final injection. 
All serum samples were divided into 0.5-1.0 ml aliquots and stored at -60°C. 
Complement Fixation Assay.  Serial twofold dilutions of rabbit anti-NSa serum, previously heat 
inactivated at 56°C for 30 min, were prepared in 0.15  M  barbitone-buffered saline, pH  7.6, 
containing 10 mM MgCIz (BBS) (29) in a volume of 40/xl each. To the antiserum dilution were 
added 20/xl of antigen (10/~g protein) in BBS or BBS alone and two minimum hemolytic doses 
of guinea pig complement in 40/~1 of BBS. After a 30-min incubation at 37°C, 50 #1 of IgM- 
sensitized sheep erythrocytes labeled with 51Cr, as previously described (30), and adjusted to 2 
×  108 cells/ml in BBS was added. After a second 30-min incubation at 37°C, 75 btl ofsupernate 
from each sample was assayed for radioactivity. For the determination of spontaneous release, 
erythrocytes were incubated as above in BBS alone. Maximum release was determined by the 
incubation of sensitized erythrocytes with complement and BBS in the place of antiserum and 
antigen. Percent lysis was calculated by the following formula: percent lysis =  ([experimental 
epm -  spontaneous cpm]/[maximum cpm -  spontaneous cpm]) ×  100. 
Immunoprecipitation of Cell Extracts.  Monolayer cultures of MDCK or MDBK cells grown in MICHAEL W.  SHAW, EDDIE W.  LAMON, AND RICHARD  W. COMPANS  245 
60-mm  plastic  petri  dishes  were  inoculated with  influenza A  or  influenza B  virus  at  a 
multiplicity of 10-20 plaque-forming units/cell in  1 ml of MEM with  1% BSA per culture. 
After a 2½-h adsorption period at 37°C, 2.5 ml of MEM supplemented with 2% calf serum was 
added to each culture. 
At 4½ h after infection, the medium was removed and the monolayers rinsed with PBS and 
incubated for 30 min in 1 ml per dish of MEM without methionine or without leueine. The 
cells were radiolabeled with  1 rnl per dish of methionine or leueine-free MEM supplemented 
with 50/~Ci  [SSS]methionine or 100/~Ci [aH]leucine, respectively. At 8 h after infection, the cell 
monolayers were rinsed with cold PBS, overlaid with 0.5 ml per dish of cell dissociation buffer 
(0.05 M Tris-HCl, 0.15  M  NaCI, 0.02  M  EDTA, I% Triton X100,  1% sodium deoxycholate, 
pH 7.5), and incubated for 30 rain at 4°C. The nuclei were pelleted out at 12,000 g for 4 min 
and the supernatants stored at -80°C until use. 
For immunoprecipitation,  extracts were mixed with 5 p,1 of rabbit antiserum and incubated 
at 37°C for 30 min. Then 100/tl of a  10% (wt/vol) suspension of Staphylococcus aureus (31) in cell 
dissociation buffer was added, and the mixture was incubated for 30 min at room temperature. 
The samples were then pelleted at  12,000 g for 3 min and the pellets washed three times, first 
with cell dissociation buffer with 0.1% sodium dodecyl sulfate (SDS) and then twice with cell 
dissociation buffer without SDS. 
The washed pellet was resuspended in 25 ~1 of deionized water and 50/~1 of 2X PAGE 
dissociation  buffer  (4%  SDS,  4%  2-mercaptoethanol  in  0.125  M  Tris-HC1,  pH  6.8)  and 
incubated at 60°C for 60 min. The slurry was pelleted at 12,000 g for 4 min and the supernate 
run on PAGE. 
Protein PAGE.  Samples were heated for 1 min at 100°C in 2% SDS and 2% 2-mercaptoeth- 
anol in 0.0625  M  Tris-HCl, pH 6.8.  Then,  14%  (or  17.5%) acrylamide, 0.093%  (or 0.116%) 
N,N'-methylenebisacrylamide  gels containing  SDS were prepared and run at a constant 15 mA 
per  3-mm  slab  gel,  as  described  by  Laemmli  (32).  Processing  and  exposing  of  gels  for 
fluorography was as described by Bonner and Laskey (33). 
Radioiodination of NS1  Protein.  Purified NS1  inclusions from WSN-infected BHK21-F cells 
were dissociated by incubation  at 60°C for 60 min in 0,01 M Tris-HC1, pH 8.5, 0.001 M EDTA, 
6 M urea, and 1 M KCI (TEU buffer). The dissociated protein and RNA were then separated 
by centrifugation (SW50.1  rotor,  48,000  rpm  for  23  h)  through a  10-20%  (wt/vol)  sucrose 
gradient prepared in TEU buffer as described elsewhere (24). The gradients were collected by 
dripping 0.4-ml fractions from the bottom of the tubes. Those fractions containing RNA-free 
NS1 protein were pooled and dialyzed against deionized water for 18 h at 4°C. The protein was 
then lyophilized and stored at -20°C until use. 
The RNA-free NS1  protein was radiolabeled with t25I by the chloramine T  method  (34) 
modified as follows: 5/tg of protein in 10/~1 of 1 M sodium phosphate buffer (pH 7.2) with 8 
M urea was mixed with 1 mCi of [12~I]Na and 10 pl of chloramine T  (2.5 mg/ml). After 15 rain 
at room temperature, an additional 10/~1 of ehloramine T  (2.5 mg/ml) was added. After a 
further 15 rain at room temperature, the reaction was mixed with 40 #1 of sodium metabisulfite 
(2.5 mg/ml), 100/~1 of KI (100 mg/ml), and 50/~1 of calf serum, and the labeled NS1 protein 
was desalted through a  column of Sephadex G-25 with TEU buffer containing 1 mg/ml of 
BSA. 
Radioimmunoassay  (RIA)for NS1.  Antibody was titrated for 50% precipitation endpoint by 
mixing 50 p.l of antiserum dilutions in 20 mM Tris-HCl, 150 mM NaC1,  1 mM EDTA, 1% 
BSA, 0.1% Sarkosyl, pH 7.4 (RIA buffer), with 50/tl of cell dissociation buffer and incubation 
for  1 h at 37°C before addition of 50 ffl of [12SI]NS1 (~ 10,000 trichloroacetic acid-precipitable 
epm in RIA buffer). After incubation for 1 h at 37°C, a  10% wt/vol suspension of S. aureus in 
RIA buffer (75 #1) was added, and the mixture was incubated at room temperature for 60 min. 
The suspension was then diluted with 1 ml of RIA buffer and pelleted by centrifugation. The 
pellets were washed twice with RIA buffer before assaying for radioactivity. Specific  precipi- 
tation was determined by subtracting cpm precipitated with normal rabbit serum from that 
precipitated with an equivalent dilution of immune serum. 
Cell extracts for use in competition radioimmunoassays were prepared by disrupting cells 
(uninfected or 24 h postinfection) in cell dissociation buffer and removing the nuclei by pelleting 
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Competition  radioimmunoassays  for  NSI  were  conducted  by  initially  mixing  50  pl  of 
antiserum diluted to its 50% precipitation titer in RIA buffer with 50 #1 of unlabeled NSt or 
cell extract dilutions in cell dissociation buffer and incubating 60 min at 37°C. Then 50 pl of 
[tzSI]NS1 (~ 10,000 TCA-precipitable cpm in RIA buffer) was added and the mixture incubated 
further for 60 min at 37°C. A  10% (wt/vol) suspension of S. aureus in RIA buffer (50 ~1) was 
then added and the mixture incubated at room temperature for 60 rain. After dilution with  1 
ml of RIA buffer, the samples were pelleted and washed twice with RIA buffer before assaying 
for radioactivity. Specific precipitation was determined as above for antibody titration. 
Results 
Titration  of Rabbit Antiserum.  The specificity and titers of antisera were determined 
by complement  fixation  tests  with  inclusions  purified  from  influenza  WSN  virus- 
infected BHK21-F cells or structural proteins from purified WSN virions as antigen. 
Antiserum raised against urea-dissociated NS1 inclusions was found to be specific for 
NS1 by the complement fixation test  (50% inhibition  of hemolysis titer -- 600), with 
no  detectable  activity  against  virus  structural  proteins  (Fig.  1).  Preimmune  serum 
from  the  same  rabbit  showed  no  discernable  reactivity  with  virus  structural  or 
nonstructural proteins. Antisera raised against intact inclusions (data not shown) gave 
a  higher anti-NSl titer  (1,200)  but also had a  high anti-NP titer (300). 
To characterize  the  specificity of antisera  by another  approach,  we analyzed the 
radiolabeled  polypeptides in immune precipitates  from cytoplasmic extracts of WSN 
virus-infected  MDBK  cells.  The  antiserum  raised  using  dissociated  inclusions  as 
immunogen was observed to be specific for NSx protein, as shown in Fig. 2. In some 
experiments,  variable amounts of NP were also seen in immune precipitates obtained 
with  this  antiserum;  however,  the  demonstration  of  a  single  polypeptide  band 
corresponding  to NS1,  as  in  Fig.  2,  lane  b,  suggests  that  the occasional presence of 
virion structural proteins in immune precipitates is due to nonspecific coprecipitation 
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FIG.  1.  Titration  of rabbit antiserum to urea-dissociated NS1 inclusions by complement fixation. 
Samples used for titration were intact  NS1 inclusions (0), purified WSN structural proteins (A), or 
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Fro.  2.  Analysis  of polypeptides  precipitated  by  antiserum  to  the  WSN  NSI  protein  from 
[aH]leucine-labeled extracts from MDCK cells infected with different influenza A virus serotypes. 
Radiolabeled  polypeptides  in cell extracts  or immune precipitates  were analyzed  by PAGE and 
fluorography, as described in Materials  and Methods.  (a) WSN-infected cell extract;  (b) immune 
precipitate  from WSN-infected cell extract;  (c) immune precipitate  from PR8-infected cell extract; 
(d) PR8-infected cell extract;  (e) immune precipitate from FW-infected cell extract;  (f) FW-infected 
cell extract; (g) immune precipitate from USSR-infected cell extract; (h) USSR-infected cell extract; 
(i)  RI-infected  cell  extract;  (j)  immune precipitate  of (i); (k)  Victoria-infected  cell extract;  (1) 
immune precipitate  of (k); (m) WSN-infected cell extract. 
Furthermore,  this  antiserum  precipitated  no  virion  structural  polypeptides  when 
reacted with  detergent-disrupted  purified virus  (not shown). 
Immunoprecipitation of Infected Cell Extracts.  To detect possible cross-reactivity in the 
antigenic determinants  among the NS1 proteins of different influenza virus strains, we 
prepared labeled cell extracts for immune precipitation  as described in Materials and 
Methods.  Immunoprecipitates  were  analyzed  by  electrophoresis  in  14%  polyacryl- 
amide  gels in  parallel  with  the  corresponding  unprecipitated  cell extracts,  as shown 
in  Fig.  2,  lanes  c-m.  In  all  cases,  the  antiserum  used  for immunoprecipitation  was 
that  raised  against  dissociated  NS1  inclusions  from  WSN-infected  cells  shown  to be 
specific for NSx by complement fixation (above). The virus strains used for comparison 
were  representative  of all  human  influenza  A  antigenic  subtypes  and  included  PR8 
(A/PR/8/34,  HIN1),  FW  (A/FW/1/50,  HINx),  USSR  (A/USSR/90/77,  H1N1),  RI 
(A/RI/5+/57,  H2N2), and Victoria  (A/Victoria/3/75,  H2N2). 
No  specific  immunoprecipitation  was  detectable  when  extracts  of  uninfected 
MDCK  cells were  treated  with  the  anti-NSt  serum  (data  not  shown).  However,  the 
antiserum  to the WSN  NS1 protein  appears to recognize  and  precipitate  virus-coded 
NS~ polypeptides from cells infected with all influenza A virus strains tested, including 
PR8  virus-infected  MDCK  cells  (Fig.  2c),  cells  infected  with  either  FW  (Fig.  2e)  or 
USSR  (Fig.  2 g)  viruses,  and  cells  infected  with  RI  (Fig.  2 j)  and  Victoria  (Fig.  2  1) 
virus.  With  some samples,  the  NP  polypeptides  and  minor amounts  of some higher 
molecular weight  polypeptides were found  in the immune precipitates.  Also, because 
the  Mx  and  NS1  proteins  of USSR  (Fig.  2 h)  and  Victoria  (Fig.  2 k)  viruses  are  not 
resolved in this  gel system, the possibility that  Ma is also present  in the  immunopre- 
cipitates  cannot  be  excluded.  These  results  are  consistent  with  the  conclusion  that 
antibody  to the  WSN-NS1  protein  is recognizing  and  precipitating  the  NS~  protein 
synthesized  by all the other influenza A  virus serotypes tested. 
Radioimmunoassay for  NS  Protein.  We  used  a  competition  radioimmunoassay  to 
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influenza virus serotypes. The NSx polypeptide from purified inclusions isolated from 
WSN virus-infected MDCK cells was separated from RNA and radiolabeled in vitro 
with lzsI, as described in Materials and Methods.  The modifications used  (increased 
oxidation  time with chloramine  T  in  the  presence of 8  M  urea)  were found  to be 
necessary  to maximize the radiolabeling  of the single  tyrosine  residue per molecule 
shown  to  be  present  in  NS1  protein  by  amino  acid  analysis  (20)  and  nucleotide 
sequencing  (35).  Under  these conditions,  the specific activity  of the labeled  sample 
was 2 ×  104 cpm/ng. 
Titration  of the  antiserum  prepared  against  dissociated  NS~  inclusions  with  the 
radioiodinated NS1 sample is shown in Fig. 3. Complete (100%) specific precipitation 
was determined  by subtraction  of the radioactivity  precipitated  by equivalent  dilu- 
tions of normal rabbit serum. Similar experiments using anti-virion serum showed no 
specific precipitation, indicating the absence of appreciable quantities of radiolabeled 
structural  antigens  in the  [125I]NSa preparation.  The  50% precipitation  endpoint  of 
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Fro.  3.  Titration of antiserum to the NS1 protein of influenza A/WSN virus with radioiodinated 
WSN NS1 protein. A 50-#1 aliquot of each antiserum dilution in RIA buffer was incubated with 50 
#1 of cell dissociation buffer and 50 #1 of [I~nI]NS1 (10,000  TCA-precipitable counts in RIA buffer) 
and the antigen-antibody complexes precipitated with S.  aureus. 
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Fro.  4.  Standardization of competition radioimmunoassay for NS] protein. The antiserum titered 
....  125~  ....  in Fig.  3  was used at  a  1:6,000  dduuon  to preclpltate [  I]NSI  after premcubatlon wlth varlous 
concentrations of unlabeled NSI. 50-#I aliquots of a  1:6,000  dilution of antiserum in RIA buffer was 
reacted with 50-#] samples of purified NSI at varying concentrations in cell dissociation buffer before 
the addition of 10,000 TCA-precipitable counts of [l~SI]NSl in RIA buffer. MICHAEL  W.  SHAW,  EDDIE  W.  LAMON,  AND  RICHARD  W.  COMPANS 
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Fro.  5.  Competition  radioimmunoassay for  NS]  using extracts  of MDCK  cells  infected  with 
different  influenza virus serotypes as  competitors.  The  assay was  performed  as  in  Fig.  4  using 
infected cell extracts in cell dissociation buffer as competitors. O, A/WSN/33; m, A/PR/8/34;  D, 
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FIo.  6.  Competition  radioimmunoassay  for  NS1  using extracts  of MDCK  cells  infected  with 
different  influenza A  virus serotypes as competitors.  The  assay was  performed  as  in  Fig.  4.  0, 
A/WSN/33; I, A/FW/t/50; D, A/USSR/90/77; ©, A/Jap/305/57;  A, A/Victoria/3/75. 
the  serum  (1:6,000)  determined  as  in  Fig.  3  was  used  in  subsequent  competition 
assays. 
Competitive binding curves were obtained using known quantities of purified NS] 
protein from inclusions obtained from BHK21-F cells infected with WSN. As shown 
in Fig. 4, the serum used at a  1:6,000 dilution titrates over a  range from ~1-100 ng 
of purified  NS].  50%  inhibition  was obtained  with  ~6.5  ng of NS1  when  50 /zl  of 
diluted serum was used. 
The competition curves obtained using cytoplasmic extracts of MDCK cells infected 
with  homologous  and  heterologous  influenza  viruses  are  shown  in  Figs.  5  and  6. 
Titrations containing >20/zg of total protein in the cell extract competitors (400 #g/ 
ml) were not possible because of nonspecific inhibition at the higher concentrations. 
The competition  curve obtained  with  WSN  virus-infected cell  extract  (Fig.  5)  was 
almost  identical  in  shape  to  that  obtained  with  purified  NSx.  Because  the  50% 
endpoint  of the  cell  extract  competition occurred  at  ~1.75  /zg of total  protein,  we 250  ANTIGENIC CROSS-REACTIVITY OF  INFLUENZA NS1  PROTEINS 
calculated that 0.4-0.5%  of the total cytoplasmic extract protein is NS1  at 8 h  after 
the infection of MDCK cells with WSN virus. 
Also shown in Fig. 5 are competition curves using extracts of MDCK cells infected 
with  PR8,  Swine,  and  B/Lee,  which  are  all  viruses  isolated  within  10  yr  of 
A/WSN/33.  The two other  influenza  A  viruses  exhibited  substantial  competition, 
indicating extensive cross-reactivity. The polyphasic nature of the curves indicates the 
presence  of at  least  two,  and  possibly  more,  independent  antigenic  determinants 
interacting with this rabbit antiserum.  The apparent  low level of competition seen 
with B/Lee/40 may be artifactual because, unlike the titration curves seen with the 
type A influenza viruses, repeated experiments gave inconsistent results. Further study 
would  be required  before any definite  conclusions  could  be  drawn  about  possible 
antigenic cross-reactivity between nonstructural  antigens of type A  and B  influenza 
viruses. 
Fig.  6  shows  the  competition  curves  obtained  with  human  influenza  A  virus 
subtypes isolated from  1950  to  1977.  All show varying degrees of competition, with 
appreciable  cross-reactivity evident  in  all  cases.  The  positions  of the  curves  with 
respect to each other suggests that the degree of cross-reactivity with the NS1 protein 
encoded by WSN is more closely related to the date of isolation rather than to the 
serotype of the surface glycoproteins;  i.e.,  the competition curve obtained with  the 
1950  isolate FW (H1N1)  is closer to that obtained with the  1957 Jap (H2N2)  virus; 
however,  USSR,  another H1N1  virus, appears more closely related  to Victoria,  an 
H3N2 subtype similar to viruses with which it circulated concurrently in  1977. 
Discussion 
We prepared monospecific antiserum to the influenza A  virus nonstructural  poly- 
peptide designated  NS1  and carried out  the  first analysis of antigenic properties of 
this polypeptide in  influenza A  viruses. While cross-reactive nonstructural  antigens 
were detected previously in cells infected with influenza A viruses by the use of mouse 
convalescent serum, the serum used might have reacted with NS2 in addition to NS1 
(12,  13). Our antigenic analyses of influenza virus NS1 protein indicate that extensive 
cross-reactivity exists between all subtypes that were examined of human influenza A 
viruses  isolated  from  1934  to  1977.  The  immunoprecipitation  studies  show  that 
antibody  to  WSN  NS1  protein  recognized  NS1  in  cells  infected  with  five different 
serotypes of influenza A virus. As revealed in these immunoprecipitation studies, NS1 
protein encoded by all subtypes of influenza A virus tested is recognized by antibody 
raised against purified NS1 polypeptides obtained from inclusions isolated from cells 
infected with the A/WSN strain. 
The  results  of competition  radioimmunoassays using  infected  or  uninfected  cell 
extracts as competitor indicated that such assays are useful for the comparison of the 
antigenic  relationships  of the  NS1  proteins  synthesized  by different  influenza  virus 
strains. The use of purified NS1 protein from all the subtypes selected for comparison 
was not possible because the isolation technique was not successful with all strains. As 
a consequence of this lack of purified competitors, the use of infected cell extracts in 
competition  radioimmunoassay  analyses  precluded  exact  comparison  of antigenic 
determinants because of nonspecific inhibition at higher total protein concentrations. 
In the assays described here, maximum inhibition levels could not be determined for 
competitors except  in  the  homologous system. The radioimmunoassay competition 
curves obtained suggested the oresence of at least two indenendent  antigenic deter- MICHAEL W.  SHAW,  EDDIE  W.  LAMON,  AND  RICHARD  W.  COMPANS  251 
minants on the NS1  molecule. The differences in  the slopes of these curves further 
suggest  that  the  various competitors bind with  different affinities.  It  is  likely that 
monoclonal antibodies to NS1, when available, will allow more precise definition of 
antigenic relationships as has been the case for the virion glycoproteins (36). 
Recent studies on influenza A virus genome segments and mRNA species support 
the  conclusions  reached  in  the  present  study.  RNA:RNA  hybridization  studies 
conducted on genome segment 8 of influenza A  virus (37)  indicate that all the non- 
avian type A viruses studied fall into a single group possessing a sequence homology 
of >90%. Studies using nucleotide sequencing techniques to deduce the amino acid 
sequences of the NS1 proteins encoded by A/PR/8/34  (H IN1), A/FPV/Rostock/34 
(HavlN1), and A/Udorn/307/72(H3N2)  viruses show that the predicted amino acid 
sequences of the NS1 proteins encoded by these strains vary by only 10-15% (35, 38, 
39). 
The rabbit  antiserum  used in the present study appeared to precipitate variable 
amounts of the viral NP protein from infected cell extracts.  However, because this 
precipitation of NP was not a constant occurrence and the results of the complement 
fixation assays indicated no activity against virion structural proteins, it seems likely 
that  the  presence of NP  in  these  immunoprecipitates  is  the  result  of nonspecific 
coprecipitation. In  addition,  the  antiserum  did not  precipitate any virion proteins 
from  purified  virus  preparations,  and  immunodiffision  studies  using  infected  cell 
extracts as antigen  (not shown) showed a single precipitin line using this antiserum. 
The reason for such coprecipitation is uncertain, but it is conceivable that it could be 
due to the association of both NSI and NP with the same cytoplasmic structures. It 
was  reported  previously that  both  polypeptides  are  associated  with  cell  fractions 
containing polysomes (19, 20). If the antibody recognized and bound to NS1 while it 
was associated with polysomes, then the resulting immunoprecipitate would probably 
contain any other proteins associated with those structures. 
Recent  studies  in  this  laboratory indicate  that  NS1  antigen  is  expressed on  the 
surfaces of infected cells  (17), suggesting  that  an  immune  response to this  protein 
could conceivably be of importance. Because the immunoprecipitation and radioim- 
munoassay results clearly show extensive antigenic cross-reactivity in the NS1 proteins 
produced by different influenza A  virus serotypes, NSl-related  antigens  should  be 
considered as  possible  targets  for cross-reactive cytotoxic T  cells  generated  during 
infection. These cytotoxic T  cells are capable of extensive cross-reactivity that is not 
limited by the surface glycoproteins serotype (41-43). Other studies have, however, 
also indicated the surface expression of other cross-reactive viral proteins including M 
(15, 44) and NP (14), although monoclonal anti-M1 IgG was not capable of blocking 
the observed cross-reactive cytotoxicity (16). 
Also, our preliminary experiments comparing acute and convalescent human sera 
indicate that anti-NS~ activity might increase during infection with the H3N2 viruses 
currently  in  circulation.  Further  information  is  needed  to  evaluate  the  immune 
response to NS1 and its possible significance. 
Summary 
We purified the major influenza virus nonstructural protein, designated NS1, from 
cytoplasmic inclusions that were solubilized and used to raise antisera in rabbits. One 
of the antisera  was  found to be specific for NSx  by complement fixation tests and 252  ANTIGENIC  CROSS-REACTIVITY  OF INFLUENZA  NS1  PROTEINS 
analyses of immune precipitates.  Antiserum  to NS1  isolated  from cells infected with 
A/WSN/33  virus  specifically  precipitated  NS1  from  extracts  of cells  infected  with 
seven  distinct  isolates  of  influenza  A  virus  representing  five  different  antigenic 
subtypes.  These  included  A/WSN/33,  A/PR/8/34,  A/FW/5/50,  A/USSR/90/77, 
A/RI/5+/57,  A/Victoria/3/75,  and  A/Swine/1977/31;  however,  NS1  from  cells 
infected with B/Lee/40 virus was not precipitated.  Radioimmunoassays using radio- 
iodinated  NS1  protein  from A/WSN  virus-infected  cells  and  unlabeled  cytoplasmic 
extracts of cells infected with various strains of influenza virus as competitors indicated 
significant  antigenic cross-reactivities  for the NS1 proteins  of all influenza A  viruses 
tested.  The  results  suggest  a  gradual  antigenic  drift  over  the  45  yr separating  the 
earliest  and  most  recent  virus  isolates  examined.  Thus,  compared  with  the  virion 
neuraminidase  and hemagglutinin  antigens,  NS1  appears  to be highly conserved in 
different influenza A  virus isolates. 
Received  for publication  6 April 1982. 
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